CM
NPTN

Crestline Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Crestline Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-101,718
Closed -$697K – 302
2018
Q1 		$697K Buy
+101,718
New +$646K 0.09% 179

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Crestline Management's NPTN Position: Q2 2018 in Review

Crestline Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2018, closing a stake of 101,718 shares — an estimated $697K sold.

Crestline Management first reported a position in NPTN in Q1 2018 and held it in 1 quarter. The position peaked at $697K in Q1 2018. 88 funds tracked by Wall St. Rank hold NPTN as of Q2 2018.

  • Crestline Management reported no remaining NEOPHOTONICS CORP position as of Q2 2018 after selling out during the quarter.
  • Crestline Management sold 101,718 NEOPHOTONICS CORP shares in Q2 2018, an estimated $697K.
  • Crestline Management first reported a position in NEOPHOTONICS CORP in Q1 2018 and held it in 1 quarter.
  • Crestline Management's NEOPHOTONICS CORP position peaked at $697K in Q1 2018.
  • 88 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2018.

Based on Crestline Management's 13F filing for Q2 2018, filed 14 Aug 2018.